Remove Competition Remove Consulting Remove Pharmacology
article thumbnail

The 5 Best Pharmaceutical Sales Training Programs

MedReps

As a result of being so desirable, the competition for these jobs is stiff. Consultative Selling. At the heart of any solid pharmaceutical sales training program is consultative selling or the act of solving problems for your customer. As mentioned, the competition for medical sales positions has been fierce recently.

article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” He is now an independent GMC consultant. About the author. CN202010111235.3A.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. These issues will be explored in the final article of this series. About the author.

FDA 98
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

She also holds post-graduate diplomas from Oxford (IP Law) as well as King’s College (EU Competition Law). Premier Consulting [Internet]. She obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. National Institutes of Health (NIH) Available from: [link] Ahn K. 2018 [cited 2024May].

Marketing 103
article thumbnail

Legal challenges put off label use of gender affirming care drugs in jeopardy

Pharmaceutical Technology

New studies for this use would be “more to satisfy those who are concerned about the provision of puberty blockers than any kind of traditional expected model of pharmacological research”. We should be having a health care system that is helping support and to raise up people to give them what they need,” he says.